article thumbnail

How Digital Technologies are Optimizing Patient/Member Health Outcomes

Omnicell

Mike Cantrell Senior Director, Regional Operations, EnlivenHealth™, an Omnicell Innovation Given the continuing effects of the COVID-19 pandemic, pharmacists are playing an increasingly important role in providing trusted, accessible and affordable healthcare.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

The investigation, which included inquiries requesting large amounts of documents and communications from various stakeholders, is largely perceived as a drug industry-friendly fact-finding exercise. 2020: After being sued once again by 340B providers, HRSA established the Administrative Dispute Resolution program.

article thumbnail

Congress Continues to Display Strong Bipartisan Support for the 340B Drug Pricing Program

Omnicell

In response to these actions, various bipartisan groups in Congress have communicated their concerns to the Department of Health and Human Services (HHS) and the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing the pharmaceutical industry in the United States.